Skip to content

Combined Intravenous and Topical Dexamethasone for Enhanced Recovery Following Total Knee Arthroplasty: A Randomized Double-Blinded Controlled Study

Combined Intravenous and Topical Dexamethasone for Enhanced Recovery Following Total Knee Arthroplasty: A Randomized Double-Blinded Controlled Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041465
Enrollment
Unknown
Registered
2020-12-26
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

B:intravenous dexamethasone 10 mg before surgery
C:intravenous and topical dexamethasone

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients requiring unilateral primary TKA surgery due to severe osteoarthritis of the knee; (2) Aged 50~80 years; (3) Body mass index was 20~35 kg/m2; (4) The American Society of Anesthesiologists (American Society of Anesthesiologists, ASA) classification (anesthesia risk assessment) is I ~ III level.

Exclusion criteria

Exclusion criteria: (1) Allergic to narcotic drugs and sulfanilamide; (2) There are more than moderate intraoperative knee malformations (internal and external varus, flexion malformations) and joint stiffness; (3) alcoholism or long-term use of opioids; (4) Language impairment and inability to complete VAS score; (5) Surgical limb neuropathy; (7) The mentally ill; (8) Patients with digestive tract ulcer.

Design outcomes

Primary

MeasureTime frame
Pain;Knee swelling;nausea and vomiting;

Secondary

MeasureTime frame
knee range of motion;KSS function score;

Countries

China

Contacts

Public ContactPengde Kang

West China Hospital, Sichuan University

kangpd@163.com+86 18980601953

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026